Topic:

Financials

Latest Headlines

Latest Headlines

GlaxoSmithKline CEO: Chin up, investors. Dividend's safe, and Novartis deal awaits

GlaxoSmithKline's shareholders may be expecting less-than-stellar sales next year as generics take their toll on respiratory behemoth Advair. But they still have plenty to look forward to, CEO Andrew Witty reminded them on Thursday.

Goldman Sachs among backers of China imaging, healthcare IT company to tune of $610M

China's Neusoft will receive $610 million from a variety of investors including Goldman Sachs to fund its medical imaging and healthcare IT ambitions.

Zoetis hikes dividend under continued pressure from activist investor Ackman

Zoetis declared on Wednesday that its first-quarter 2015 dividend would be 8.3 cents per share, marking a 15% increase over this year's dividend rate.

Myriad Genetics stymied in BRCA breast cancer test patent battle

Myriad Genetics lost big in its fight to keep competing breast cancer DNA tests off the market, as a U.S. appeals court ruled that its patents are not eligible for legal protection.

European diagnostics startups Protagen and 14M close venture rounds

A pair of European diagnostics companies have wrapped up venture financings. Autoimmune diagnostician Protagen had a first close of a €10 million ($12.5 million) financing, while cancer genomic diagnostics company, 14M Genomics, a spinout of the Wellcome Trust Sanger Institute, got £12.5 million ($19.6 million).

First pathogen-reduction system for plasma approved by FDA

Small cap Cerus gained more than 10% in early trading on Dec. 17 after the FDA approved its Intercept Blood System for plasma. This is the first pathogen-reduction system approved by the regulator to prepare plasma to reduce the risk of transfusion-transmitted infections.

Belgium's UCB calls it quits on $1.53B sale of U.S. generic drug unit

Weeks after Belgium's UCB announced that it would sell its U.S. generic drug business for $1.53 billion, the company is calling off the sale in light of regulatory pushback over one of the unit's products.

Salix expects lackluster sales as it speeds to fix inventory issues

Back in November, Salix revealed some inventory issues that had skewed perceived demand for some of its products--and possibly cost it a deal with Allergan in the process. Now, the company says it's moving to fix the problem quickly. But in the meantime, its top line will pay the price.

Medtronic launches biofragmentable, injectable nasal packing and stent for sinus surgery

Medtronic has launched NovaShield Injectable Nasal Packing and Stent for functional endoscopic sinus surgery after an FDA approval in October. It's a gel made from chitosan that's placed in the sinus or nasal cavities after the surgery.

GE-backed InSightec gets $59M for noninvasive surgical tool, adds ex-Mako CEO to board

Israeli medical device company InSightec closed a $59 million Series D round led by major institutional investors in the U.S. and Asia. It's left room for existing shareholders to invest an additional $3.5 million through the end of January.